Schilddrüsenkarzinom: RET-Inhibitor bewährt sich auch in der Praxis
Crossref DOI link: https://doi.org/10.1007/s15015-022-3895-y
Published Online: 2022-06-28
Published Print: 2022-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Freye, Reimund
Text and Data Mining valid from 2022-06-28
Version of Record valid from 2022-06-28
Article History
First Online: 28 June 2022
Free to read: This content has been made available to all.